sulforaphane has been researched along with Friedreich Disease in 3 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Excerpt | Relevance | Reference |
---|---|---|
"Sulforaphane (SFN) is a natural compound of many diets and is now being used in clinical trials for other pathologies." | 1.46 | Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia. ( Bertini, E; Carrozzo, R; Pastore, A; Petrillo, S; Piemonte, F; Piermarini, E; Schirinzi, T; Vasco, G, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Petrillo, S | 2 |
D'Amico, J | 1 |
La Rosa, P | 1 |
Bertini, ES | 1 |
Piemonte, F | 2 |
Chiang, S | 1 |
Huang, MLH | 1 |
Richardson, DR | 1 |
Piermarini, E | 1 |
Pastore, A | 1 |
Vasco, G | 1 |
Schirinzi, T | 1 |
Carrozzo, R | 1 |
Bertini, E | 1 |
3 other studies available for sulforaphane and Friedreich Disease
Article | Year |
---|---|
Targeting NRF2 for the Treatment of Friedreich's Ataxia: A Comparison among Drugs.
Topics: Acetylcysteine; Biopsy; Down-Regulation; Drug Evaluation, Preclinical; Frataxin; Friedreich Ataxia; | 2019 |
Treatment of dilated cardiomyopathy in a mouse model of Friedreich's ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis.
Topics: Acetylcysteine; Animals; Basic-Leucine Zipper Transcription Factors; Cardiomyopathy, Dilated; Cell L | 2020 |
Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia.
Topics: Adolescent; Adult; Cells, Cultured; Child; Female; Fibroblasts; Frataxin; Friedreich Ataxia; Humans; | 2017 |